Skip to Content

Organic Farming “Benefits Biodiversity”
… but has lower yields.
Antonio Regalado, senior editor, biomedicine

A Way to Brew Morphine Raises Concern over Regulation
Federal drug regulatory authorities may have a new challenge on their hands: yeast genetically modified to make morphine.
Mike Orcutt, research editor

New Patent Lawsuits Are Down for the First Time in Five Years. Here’s Why That’s a Huge Deal.
Patent lawsuits remain at astronomical levels. But they might be getting a bit rarer.
Brian Bergstein, executive editor

This Is What Happens After You Die
An entomologically oriented and slightly morbid breakdown of how the human body decomposes after death.
—Kyanna Sutton, senior Web producer

What You Need to Know About Twitter
This podcast offers an amusing two-man take on the evolution of Twitter.
—Kyanna Sutton

Altering Course
Physicist Mara Prentiss thinks a shift away from fossil fuels is “not only possible, but probable.”
—J. Juniper Friedman, associate Web producer

Americans’ Attitudes About Privacy, Security and Surveillance
“A cloud of personal ‘data insecurity’ looms over many Americans’ daily decisions and activities,” says a new report that surveyed people’s trust in the corporations and government agencies holding their personal data.
Tom Simonite, San Francisco bureau chief

Why Won’t Twitter Forgive Suey Park?
Monica Lewinsky aside, the Internet doesn’t pardon everyone.
Nanette Byrnes, senior editor, Business Reports

A Giant, Fake City in the Middle of the Desert
Pegasus Global Holdings is spending a billion dollars on a ghostly uninhabited town—perhaps complete with public art—to test technologies and products for the cities of the future.
—Linda Lowenthal, copy chief

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.